PL358184A1 - Pochodne sulfonamidów - Google Patents

Pochodne sulfonamidów

Info

Publication number
PL358184A1
PL358184A1 PL01358184A PL35818401A PL358184A1 PL 358184 A1 PL358184 A1 PL 358184A1 PL 01358184 A PL01358184 A PL 01358184A PL 35818401 A PL35818401 A PL 35818401A PL 358184 A1 PL358184 A1 PL 358184A1
Authority
PL
Poland
Prior art keywords
sulfonamide derivatives
sulfonamide
derivatives
Prior art date
Application number
PL01358184A
Other languages
English (en)
Inventor
James Abraham Aikins
Andrew Hendley Fray
William David Miller
Paul Leslie Ornstein
Hamideh Zarrinmayeh
Dennis Michael Zimmerman
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of PL358184A1 publication Critical patent/PL358184A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL01358184A 2000-05-19 2001-05-04 Pochodne sulfonamidów PL358184A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20582200P 2000-05-19 2000-05-19
PCT/US2001/011746 WO2001090056A1 (en) 2000-05-19 2001-05-04 Sulfonamide derivatives

Publications (1)

Publication Number Publication Date
PL358184A1 true PL358184A1 (pl) 2004-08-09

Family

ID=22763775

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01358184A PL358184A1 (pl) 2000-05-19 2001-05-04 Pochodne sulfonamidów

Country Status (25)

Country Link
US (2) US6720357B2 (pl)
EP (1) EP1296944A1 (pl)
JP (1) JP2003534315A (pl)
KR (1) KR20030007643A (pl)
CN (1) CN1429206A (pl)
AR (1) AR028590A1 (pl)
AU (1) AU2001262936A1 (pl)
BR (1) BR0110871A (pl)
CA (1) CA2409829A1 (pl)
CZ (1) CZ20023796A3 (pl)
DZ (1) DZ3344A1 (pl)
EA (1) EA004868B1 (pl)
EC (1) ECSP014079A (pl)
HR (1) HRP20020917A2 (pl)
HU (1) HUP0302291A3 (pl)
IL (1) IL152154A0 (pl)
MX (1) MXPA02010021A (pl)
NO (1) NO20025533L (pl)
NZ (1) NZ521620A (pl)
PE (1) PE20011260A1 (pl)
PL (1) PL358184A1 (pl)
SK (1) SK16322002A3 (pl)
SV (1) SV2002000458A (pl)
WO (1) WO2001090056A1 (pl)
ZA (1) ZA200208746B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA59384C2 (uk) * 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
WO2003032974A2 (en) * 2001-10-12 2003-04-24 Eli Lilly And Company Use of sulfonamide derivatives as pharmaceuticals compounds
WO2005013961A1 (en) * 2003-07-17 2005-02-17 Eli Lilly And Company Combination therapy for treatment of cognitive disorders or psychoses
JP2007521322A (ja) * 2003-09-18 2007-08-02 メルク　エンド　カムパニー　インコーポレーテッド 置換スルホンアミド類
AP3066A (en) 2009-06-26 2014-12-31 Pfizer Heterocyclic sulfonamides, uses and pharmaceuticalcompositions thereof
KR101569842B1 (ko) 2009-09-30 2015-11-17 삼성전자 주식회사 텔레비전용 전원공급유닛 및 이를 포함하는 텔레비전
WO2011109398A2 (en) 2010-03-02 2011-09-09 President And Fellows Of Harvard College Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
WO2014201411A1 (en) 2013-06-13 2014-12-18 Veroscience Llc Compositions and methods for treating metabolic disorders
WO2018009256A1 (en) 2016-03-29 2018-01-11 Respirerx Pharmaceuticals, Inc. Compositions and methods for treating attention deficit disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
DE69917278T2 (de) 1998-07-31 2005-05-19 Eli Lilly And Co., Indianapolis Heterocyclyl sulphonamid derivate
PE20000942A1 (es) 1998-07-31 2000-09-28 Lilly Co Eli Derivados de amida, carbamato y urea
US6525099B1 (en) 1998-07-31 2003-02-25 Eli Lilly And Company N-substituted sulfonamide derivatives
PE20000943A1 (es) 1998-07-31 2000-09-28 Lilly Co Eli Derivados de sulfonamida

Also Published As

Publication number Publication date
NZ521620A (en) 2004-08-27
BR0110871A (pt) 2003-02-11
US6803484B2 (en) 2004-10-12
EP1296944A1 (en) 2003-04-02
SV2002000458A (es) 2002-10-24
WO2001090056A1 (en) 2001-11-29
HUP0302291A2 (hu) 2003-11-28
US6720357B2 (en) 2004-04-13
IL152154A0 (en) 2003-05-29
MXPA02010021A (es) 2003-02-12
DZ3344A1 (fr) 2001-11-29
US20040143020A1 (en) 2004-07-22
PE20011260A1 (es) 2001-12-11
US20030233015A1 (en) 2003-12-18
ZA200208746B (en) 2004-02-10
JP2003534315A (ja) 2003-11-18
ECSP014079A (es) 2002-02-25
AR028590A1 (es) 2003-05-14
KR20030007643A (ko) 2003-01-23
SK16322002A3 (sk) 2003-05-02
NO20025533L (no) 2003-01-20
HUP0302291A3 (en) 2006-11-28
CA2409829A1 (en) 2001-11-29
EA004868B1 (ru) 2004-08-26
EA200201232A1 (ru) 2003-04-24
CN1429206A (zh) 2003-07-09
HRP20020917A2 (en) 2004-02-29
NO20025533D0 (no) 2002-11-18
AU2001262936A1 (en) 2001-12-03
CZ20023796A3 (cs) 2003-04-16

Similar Documents

Publication Publication Date Title
EG22695A (en) Novel phenyl-propargylether derivatives
IL152783A0 (en) 2-aminocarbonyl-9h-purine derivatives
HRP20030055A2 (en) 4-phenyl-pyridine derivatives
IL150841A0 (en) 1h-imidazopyridine derivatives
PL368816A1 (pl) 3-podstawione pochodne 4-pirymidonu
AU1397802A (en) Substituted c-cyclohexylmethylamine derivatives
HUP0401949A3 (en) 4-imidazolin-2-one derivatives
PL356565A1 (pl) Pochodne aminosulfonylobifenylu
AU2001241512A1 (en) Sulfonamide derivatives
IL150557A0 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives
AU8993701A (en) Substituted 1-aminobutan-3-ol derivatives
AU2001274265A1 (en) Sulphonamide derivatives
AU2001280470A1 (en) Heterocyclic sulfonamide derivatives
AU2001282865A1 (en) Heterocyclic sulfonamide derivatives
PL358184A1 (pl) Pochodne sulfonamidów
IL152156A0 (en) Sulfonamide derivatives
IL150558A0 (en) Aminomethyl-phenyl-cyclohexanone derivatives
EP1364954A4 (en) Dicarba closo DODECARBORANDERIVATE
IL155104A0 (en) 5-amino-1-pentene-3-ol substituted derivatives
AU2001284649A1 (en) Acetylenic sulfonamide derivatives
EP1408955A4 (en) NEW METALLOTEXAPHYRINE DERIVATIVES
IL151598A0 (en) 2-phenylpyran-4-one derivatives
HK1055290A (en) Sulfonamide derivatives
HK1056867A (en) Sulfonamide derivatives
GB0021639D0 (en) Maurotoxin derivatives

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)